procainamide has been researched along with Red-Cell Aplasia, Pure in 2 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Red-Cell Aplasia, Pure: Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pasha, SF | 1 |
| Pruthi, RK | 1 |
| Agudelo, CA | 1 |
| Wise, CM | 1 |
| Lyles, MF | 1 |
1 review available for procainamide and Red-Cell Aplasia, Pure
| Article | Year |
|---|---|
Pure red cell aplasia in procainamide induced systemic lupus erythematosus. Report and review of the literature.
Topics: Aged; Humans; Lupus Erythematosus, Systemic; Male; Procainamide; Red-Cell Aplasia, Pure | 1988 |
1 other study available for procainamide and Red-Cell Aplasia, Pure
| Article | Year |
|---|---|
Procainamide-induced pure red cell aplasia.
Topics: Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Procainamide; Red-Cell Aplasia, Pure | 2006 |